Previous US studies have found racial disparities in triple-negative breast cancer diagnoses, but few have looked beyond the scope of one state. To conduct a larger study, researchers analyzed all breast cancer cases diagnosed during 2010-14 from the United States Cancer Statistics database, a surveillance system of cancer registries with data representing 99 percent of the US population.
from Women's Health News -- ScienceDaily https://ift.tt/2Jufiv3
Wednesday, July 10, 2019
Why sex becomes less satisfying with age
The number of women regularly having sex declines with age, and the number of women enjoying sex postmenopause is even lower. Although these facts are not surprising, the causes for these declines may be because previous research focused largely on biological causes only. However, a new study identifies psychosocial contributors.
from Women's Health News -- ScienceDaily https://ift.tt/30toSUo
from Women's Health News -- ScienceDaily https://ift.tt/30toSUo
Tuesday, July 9, 2019
Killing the seeds of cancer: A new finding shows potential in destroying cancer stem cells
When doctors remove a tumor surgically or use targeted therapies, the cancer may appear to be gone. However, evidence suggests a tiny subpopulation of adaptable cancer cells can remain and circulate through the body to seed new metastasis in far-off locations. A collaborative research project has identified an entirely new class of molecules that shows promise in rooting out and killing those cancer stem cells.
from Breast Cancer News -- ScienceDaily https://ift.tt/2xHvBxy
from Breast Cancer News -- ScienceDaily https://ift.tt/2xHvBxy
Knowing BRCA status associated with better breast cancer outcomes even without surgery
Women who knew their BRCA+ status were diagnosed with earlier stage breast cancer, needed less chemotherapy, less extensive surgery, and had greater overall 5-year survival (98 percent vs. 74 percent).
from Breast Cancer News -- ScienceDaily https://ift.tt/2XDn6hA
from Breast Cancer News -- ScienceDaily https://ift.tt/2XDn6hA
Knowing BRCA status associated with better breast cancer outcomes even without surgery
Women who knew their BRCA+ status were diagnosed with earlier stage breast cancer, needed less chemotherapy, less extensive surgery, and had greater overall 5-year survival (98 percent vs. 74 percent).
from Women's Health News -- ScienceDaily https://ift.tt/2XDn6hA
from Women's Health News -- ScienceDaily https://ift.tt/2XDn6hA
Knowing BRCA status associated with better breast cancer outcomes even without surgery
Women who knew their BRCA+ status were diagnosed with earlier stage breast cancer, needed less chemotherapy, less extensive surgery, and had greater overall 5-year survival (98 percent vs. 74 percent).
from Women's Health News -- ScienceDaily https://ift.tt/2XDn6hA
from Women's Health News -- ScienceDaily https://ift.tt/2XDn6hA
Monday, July 8, 2019
Eggshells can help grow, heal bones
Eggshells can enhance the growth of new, strong bones needed in medical procedures, a team of researchers has discovered.
from Women's Health News -- ScienceDaily https://ift.tt/30lAkkV
from Women's Health News -- ScienceDaily https://ift.tt/30lAkkV
Eggshells can help grow, heal bones
Eggshells can enhance the growth of new, strong bones needed in medical procedures, a team of researchers has discovered.
from Women's Health News -- ScienceDaily https://ift.tt/30lAkkV
from Women's Health News -- ScienceDaily https://ift.tt/30lAkkV
Cancer genes and the tumor milieu
Researchers demonstrate the role of an oncogene in altering the immediate environment of tumors.
from Breast Cancer News -- ScienceDaily https://ift.tt/2G2mxb8
from Breast Cancer News -- ScienceDaily https://ift.tt/2G2mxb8
Discovery of mechanism behind precision cancer drug opens door for more targeted treatment
New research that uncovers the mechanism behind the newest generation of cancer drugs is opening the door for better targeted therapy. PARP inhibitors are molecular targeted cancer drugs used to treat women with ovarian cancer who have the BRCA1 and BRCA2 gene mutations. The drugs are showing promise in late-stage clinical trials for breast cancer, prostate cancer and pancreatic cancer.
from Breast Cancer News -- ScienceDaily https://ift.tt/2G0VWeK
from Breast Cancer News -- ScienceDaily https://ift.tt/2G0VWeK
Subscribe to:
Posts (Atom)